¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"diffuse infantile familial sclerosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • diffuse placenta
    ÆÛÁøÅ¹Ý
  • diffuse proliferative glomerulonephritis
    ±¤¹üÀ§Áõ½ÄÅ丮ÄáÆÏ¿°, ±¤¹üÀ§Áõ½Ä»ç±¸Ã¼½Å¿°
  • diffuse reflection
    ±¤¹üÀ§¹Ý»ç
  • diffuse scleritis
    ±¤¹üÀ§°ø¸·¿°
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • subacute diffuse glomerulonephritis
    ¾Æ±Þ¼º»êÀçÅ丮ÄáÆÏ¿°, ¾Æ±Þ¼º¹ü¹ß»ç±¸Ã¼½Å¿°
  • infantile
    ¿µ¾Æ-
  • infantile amnesia
    ¿µ¾Æ±â±â¾ï»ó½Ç
  • infantile autism
    À¯¾ÆÀÚÆóÁõ, ¿µ¾ÆÀÚÆóÁõ
  • infantile automatism
    ¿µ¾ÆÀÚµ¿Áõ, Á¥¸ÔÀÌÀÚµ¿Áõ
  • infantile cortical hyperostosis
    ¿µ¾Æ°ÑÁú»À°ú´ÙÁõ, ¿µ¾ÆÇÇÁú°ú°ñÁõ
  • infantile dermatitis
    ¿µ¾ÆÇǺο°
  • infantile diarrhea
    ¿µ¾Æ¼³»ç
  • infantile diplegia
    ¿µ¾Æ¾çÃø¸¶ºñ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • diffuse reflection
    ¹Ì¸¸¼º¹Ý»ç
  • diffuse scleritis
    ±¤¹üÀ§°ø¸·¿°
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • diffuse collagen disease
    ±¤¹üÀ§¾Æ±³Áúº´, ¹Ì¸¸¾Æ±³Áúº´
  • diffuse cutaneous mastocytosis
    È®»êÇǺκñ¸¸¼¼Æ÷Áõ
  • diffuse esophageal spasm
    È®»ê½Äµµ¿¬Ãà
  • diffuse interstitial pulmonary disease
    ±¤¹üÀ§»çÀÌÁúÆóº´, ¹Ì¸¸°£ÁúÆóº´
  • diffuse proliferative glomerulonephritis
    »êÀçÁõ½ÄÅ丮ÄáÆÏ¿°, ¹Ì¸¸Áõ½Ä»ç±¸Ã¼½Å¿°
  • subacute diffuse glomerulonephritis
    ¾Æ±Þ¼º»êÀçÅ丮ÄáÆÏ¿°, ¾Æ±Þ¼º¹ü¹ß»ç±¸Ã¼½Å¿°
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • infantile amnesia
    À¯¾Æ±â±â¾ï»ó½Ç
  • infantile articulation
    ¿µ¾ÆÀÔ¼Ò¸®, ¿µ¾Æ±¸À½
  • infantile autism
    À¯¾ÆÀÚÆóÁõ, ¿µ¾ÆÀÚÆóÁõ
  • infantile automatism
    ¿µ¾ÆÀÚµ¿Áõ, Á¥¸ÔÀÌÀÚµ¿Áõ
  • infantile beriberi
    ¿µ¾Æ°¢±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • posterior spinal sclerosis
    ÈÄô¼ö°æÈ­Áõ (¡­Ìãûùñø).
  • posterior spinal sclerosis
    ÈÄô¼ö°æÈ­Áõ(ý­ô±âÐÌãûùñø)
  • posterolateral sclerosis
    ÈÄ»èÃø»è°æÈ­Áõ.
  • posterolateral sclerosis
    ÈÄ»èÃø»è°æÈ­Áõ(ÈÄ»èÃø»èÌãûùñø)
  • posterolateral sclerosis syndrome
    ÈÄ»èÃø»è°æÈ­ÁõÁõÈıº.
  • presenile sclerosis
    Ãʷμº °æÈ­(Áõ) (¡­Ìãûùñø).
  • presenile sclerosis
    Ãʷμº °æÈ­(Áõ)(ôøÖÕàõ Ìãûùñø)
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(¡­ö°ßãÌãûùñø).
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(ê«Û¡(àõ) ö°ßãÌãûùñø)
  • primary posterolateral sclerosis
    ¿ø¹ß(¼º) ÈÄ¿ÜÃø»è°æÈ­(Áõ).
  • primary posterolateral sclerosis
    ¿ø¹ß(¼º) ÈÄ¿ÜÃø»è°æÈ­(Áõ)(ê«Û¡(àõ) ý­èâö°ßãÌãûù(ñø))
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å °æÈ­Áõ
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å¼º °æÈ­Áõ(Ìãûùñø)
  • progressive systemic sclerosis
    ÁøÇà(¼º) Àü½Å°æÈ­Áõ
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • diffuse granulomatosis
    ¹Ì¸¸¼º À°¾ÆÁ¾(Áõ).
  • diffuse inflammation
    ¹Ì¸¸¼º ¿°Áõ.
  • diffuse interstitial keratitis
    ±¤¹üÀ§°£Áú°¢¸·¿°, ¹Ì¸¸¼º°£Áú°¢¸·¿°
  • diffuse interstitial pneumonia
    ¹Ì¸¸¼º °£Áú¼º Æó·Å.
  • diffuse interstitial pulmonary disease
    ¹Ì¸¸¼º °£Áú¼º ÆóÁúȯ
  • diffuse interstitial pulmonary fibrosis
    ¹Ì¸¸¼º °£Áú¼º Æó¼¶À¯Áõ.
  • diffuse intravascular coagulation
    ¹ü¹ß¼º Ç÷°ü³»ÀÀ°í.
  • diffuse intravascular coagulopathy
    ¹ü¹ß¼º Ç÷°ü³» ÀÀ°íº´Áõ.
  • diffuse intravascular coagulopathy
    ¹Ì¸¸¼º ¹ü¹ß¼º Ç÷°ü³» ÀÀ°íº´Áõ.
  • diffuse labyrinthitis
    ¹Ì¸¸(¼º) ³»ÀÌ¿°, ¹Ì¸¸(¼º) ¹Ì·Î
  • diffuse nontoxic goiter
    ¹ü¹ß¼º ºñÁßµ¶¼º °©»ó¼±Á¾(¹ü¹ß¼ººñÁßµ¶¼º°©»ó¼±Á¾) .
  • diffuse nontoxic goiter
    ¹ü¹ß¼º ºñÁßµ¶¼º °©»ó¼±Á¾(ÛñÛ¡àõÞªñéÔ¸àõË£ßÒàÍðþ) .
  • diffuse pericementitis
    ¹Ì¸¸¼º Ä¡±Ù¸·¿°(¡­öÍÐÆØ¯æú).
  • diffuse peritonitis
    ¹Ì¸¸¼º º¹¸·¿°(¡­º¹¸·¿°).
  • diffuse peritonitis
    ¹Ì¸¸¼º º¹¸·¿°(¡­ÜÙØ¯æú).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DILD diffuse infiltrative lung disease; diffuse interstitial lung disease
FHH Familial Hypocalciuric Hypercalcemia
  = Familial Benign Hypercalcemia
FAD familial Alzheimer dementia; familial autonomic dysfunction; fetal activity-acceleration determinati...
FAP familial adenomatous polyposis; familial amyloid polyneuropathy; fatty acid polyunsaturated; fatty a...
CIHS central infantile hypotonic syndrome
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
I.A. infantile autism
ICP infantile cerebral paralyses
AHS Ammon's horn sclerosis
ALS amylotrophic lateral sclerosis
DLCL B-diffuse large-cell lymphomas
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • annular sclerosis
    À±»ó °æÈ­Áõ
    ôÃß ÁÖÀ§¿¡ ´ë»óÀ¸·Î »ý±â´Â °æÈ­Áõ.
  • areolar choroidal sclerosis
    ¿øÇü ¸Æ¶ô¸· °æÈ­
  • condylar sclerosis
    °úµÎ °æÈ­Áõ
  • dentinal sclerosis
    »ó¾Æ ¼¼°ü °æ»ö, »ó¾ÆÁú °æÈ­Áõ
    Àڱؿ¡ ´ëÇÑ »ó¾ÆÁúÀÇ ¹ÝÀÀÀ¸·Î¼­ »ó¾Æ¼¼°üÀÇ Á¡Â÷ÀûÀÎ ¼®È¸È­¸¦ ¸»ÇÑ´Ù. ÀÌ´Â ¿ì½Ä, ±³¸ðÁõ, ¶Ç´Â Ä¡°æºÎ ¸¶¸ðÁõ¿¡ ÀÇÇØ »ó¾ÆÁúÀÌ ±¸°­ ȯ°æ¿¡ ¸¸¼ºÀûÀ¸·Î ³ëÃâµÇ´Â °æ¿ì ¹ß»ýµÇ¸ç ³ëÃâµÈ »ó¾ÆÁúÀº À¯¸®¿Í °°ÀÌ ¹Ý¦À̴ ǥ¸é Áú°¨À» °®°í ÀÖ´Ù. ÇÑÆí, »ó¾ÆÁú¿¡ ´ëÇÑ ¿­Àû, È­ÇÐÀû, Ã˰¢ÀûÀÎ Àڱؿ¡ ´ëÇØ Ä¡¼ö¸¦ È¿°úÀûÀ¸·Î º¸È£ÇÏ´Â ÀÛ¿ëÀ» Áö´Ï°í ÀÖ´Ù.
  • lichen sclerosis et atrophicus
    °æÈ­ À§Ã༺ ÆíÆò ż±
    ¸¸¼º À§Ã༺ÀÇ ÇǺΠÁúȯÀ¸·Î, ºÎÁ¤ÇüÀÇ ÆíÆòÇÑ ±¸ÁøÀÌ °¢Àü°ú ÇÔ¿ä¿¡ ÀÇÇÏ¿© ´ÙÇü¼ºÀ» ³ªÅ¸³»´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. ³²ÀÚ´Â À½°æ¿¡ ¹ß»ýÇÏ´Â Æó»ö¼º °ÇÁ¶¼º ±ÍµÎ¿°°ú ¿©ÀÚÀÇ ¿ÜÀ½ºÎ¿¡ ¹ßº´ÇÏ´Â ¿ÜÀ½ À§Ãà ÁõÀÇ °¡Àå ÈçÇÑ ¿øÀÎÀÌ µÈ´Ù.
  • muscle sclerosis
    ±Ù °æÈ­Áõ
  • posterolateral sclerosis syndrome
    ÈÄ»è Ãø»è °æÈ­Áõ ÁõÈıº
  • primary lateral sclerosis
    ¿ø¹ß¼º Ãø»ö °æÈ­Áõ
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °øÇÇÁõ
  • pulmonary sclerosis
    Æó °æÈ­Áõ
  • pulp sclerosis
    Ä¡¼ö ¼®È¸Áõ
    Ä¡¼ö°­°ú Ä¡±Ù°ü¿¡¼­ ¹ß»ýµÇ´Â ¶Ç ´Ù¸¥ ÇüÅÂÀÇ ¼®È¸È­ Çö»óÀÌ´Ù. Ä¡¼ö¼®°ú´Â ´Þ¸® Ä¡¼ö ¼®È¸ÁõÀº ´õ¿í ±¤¹üÀ§ÇÑ ÇüÅÂÀÌ´Ù. ¿øÀÎÀº Àß ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀ¸³ª ¿¬·É°ú Å« °ü°è°¡ ÀÖ´Â °Í °°´Ù. 10-20¼¼ÀÇ ¸ðµç Ä¡¾Æ Áß 60%, 50-70¼¼ÀÇ ¸ðµç Ä¡¾Æ Áß 90%°¡ Á¶Á÷ÇÐÀûÀ¸·Î Ä¡¼ö ¼®È¸ÁõÀÇ ¼Ò°ßÀ» º¸¿´°í Á¶Á÷ÇÐÀûÀ¸·Î ¼®È¸È­ÀÇ ÇüÅ´ ¹«Á¤ÇüÀÌ°í ¹«±¸Á¶¸¦ º¸ÀÌÁö¸¸ Ä¡¼ö¿¡ ÀÖ´Â Ç÷°ü°ú ½Å°æ¿¡ ÆòÇàÇÑ ´ë»ó
  • sclerosis
    °æÈ­, °æÈ­Áõ, °ñ °æÈ­Áõ, °æ°á, °æÈ­
    ƯÈ÷ ¿°Áõ ¹× °£Áú Áúȯ¿¡ ÀÇÇØ¼­ »ý±â´Â ºÎºÐÀû °æÈ­·Î¼­, ÀÌ ¿ë¾î´Â ÁÖ·Î °áÇÕ Á¶Á÷ÀÇ °úÇü¼º¿¡ ÀÇÇÑ ½Å°æ°èÀÇ °æÈ­ ¶Ç´Â Ç÷°üÀÇ °æÈ­¿¡ ´ëÇØ¼­ »ç¿ëµÈ´Ù.
  • subchondral sclerosis
    ¿¬°ñÇÏ °æÈ­Áõ
  • subepithelial deposit and sclerosis
    »óÇÇÇÏ ÃàÀû°ú °æÈ­
  • systemic sclerosis
    Àü½Å¼º °æÈ­Áõ, °øÇÇÁõ. °æÇÇÁõ
    ÇǺÎ, ½ÉÀå, ½Äµµ, ½ÅÀå ¹× Æó¸¦ Æ÷ÇÔÇÑ ½Åü ¸ðµç ºÎÀ§ °áÇÕ Á¶Á÷ÀÇ ¸¸¼ºÀûÀÎ °æÈ­ ¹× À§Ãà. ÇǺδ ºñÈÄ, °æÈ­, °­Á÷µÇ°í Âø»öµÈ ¹ÝÀÌ »ý±ä´Ù. À̰ÍÀº Àü½Å¼ºÀÎ °æ¿ì »çÁöÀÇ ¸»´ÜºÎ³ª ¾ó±¼ ¶Ç´Â ¼Õ°¡¶ô¿¡ ±¹ÇÑµÈ °æ¿ì, EH´Â Á÷°æ ¼ö cmÀÇ l ³­Çü ¶Ç´Â ¼±»ó ¿µ¿ª¿¡ ±¹ÇÑ µÈ °æ¿ì°¡ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
nuclear sclerosis Increased refractivity of the central portion of the lens of the eye.
See: nuclear cataract.
(05 Mar 2000)
systemic sclerosis <rheumatology> A multisystem disorder of unknown aetiology. It is characterised by fibrosis (scarring) of the skin, blood vessels and internal organs. Involvement of the gastrointestinal tract, heart, kidneys and lungs is common.
(09 Jan 1998)
disseminated sclerosis <neurology> Neurodegenerative disease characterised by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in 3rd or 4th decade with intermittent progression over an extended period. Cause still uncertain.
(18 Nov 1997)
idiopathic hypercalcaemic sclerosis of infants See: idiopathic hypercalcaemia of infants.
(05 Mar 2000)
insular sclerosis <neurology> Neurodegenerative disease characterised by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in 3rd or 4th decade with intermittent progression over an extended period. Cause still uncertain.
(18 Nov 1997)
ovulational sclerosis A slowly progressive sclerosis in the walls of the ovarian arteries which commences after puberty.
Synonym: menstrual sclerosis, ovulational sclerosis.
(05 Mar 2000)
endocardial sclerosis <radiology> Unknown aetiology, diffuse thickening of endocardium, few live more than 2 yrs, limited to left chambers in 80%, causes restrictive cardiomyopathy
(12 Dec 1998)
tuberous sclerosis <radiology> (Bourneville disease) autosomal dominant phakomatosis classic triad: seizures, retardation, adenoma sebaceum, calcified subependymal hamartomas, uncalcified tubers in cerebral cortex, enhancing lesion most likely to be malignant transformation to giant cell astrocytoma associated with: skin lesions, angiomyolipoma, increased risk of renal cell carcinoma
(12 Dec 1998)
unicellular sclerosis A growth of fibrous tissue between and isolating the individual cells of a part.
(05 Mar 2000)
focal sclerosis <neurology> Neurodegenerative disease characterised by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in 3rd or 4th decade with intermittent progression over an extended period. Cause still uncertain.
(18 Nov 1997)
focal sclerosis with hyalinosis <nephrology> A kidney disorder that results in fibrosis and scarring in the kidney glomerulus. The cause is unknown but some cases can result from reflux nephropathy. The clinical manifestation of this kidney disorder is nephrotic syndrome.
Symptoms include weight gain, swelling, hypertension and foamy urine. High blood cholesterol and triglyceride levels are also seen with this disorder. Treatment has included the use of corticosteroids and immunosuppressives. Antihypertensive agents and diuretics may also be necessary. Over one-half will develop chronic renal failure within 10 years of diagnosis.
(27 Sep 1997)
laminar cortical sclerosis A degeneration of nerve fibres in the corona radiata in a laminar pattern.
(05 Mar 2000)
lateral spinal sclerosis Considered by many to be a subgroup of motor neuron disease; a slowly progressive degenerative disorder of the motor neurons of the cerebral cortex, resulting in widespread weakness on an upper motor neuron basis; spasticity, hyperreflexia, and Babinski signs are present, but not fasciculation potentials, nor any electrodiagnostic evidence of a lower motor neuron lesion.
Synonym: lateral spinal sclerosis.
(05 Mar 2000)
lobar sclerosis Circumscribed atrophy of the cerebral cortex.
Synonym: lobar sclerosis, progressive circumscribed cerebral atrophy.
(05 Mar 2000)
aggressive infantile fibromatosis A childhood counterpart of abdominal or extra-abdominal desmoid tumours, characterised by firm subcutaneous nodules that grow rapidly in any part of the body that invade locally and recur but do not metastasize.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á